Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing ...
SAN DIEGO, and GREENWOOD, S.C., March 24, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) and Greenwood Genetic Center (GGC) today announced a publication in Genome Research describing ...
High detection accuracy: OGM identified 84 out of 85 (98.8%) pathogenic repeat expansions. No apparent upper size limit: OGM measured accurately the repeat sizes, even for extremely long expansions ...
New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has ...
Publication shows that OGM can resolve translocation partners involving MYC in multiple myeloma (MM) more effectively than current methods The release of compelling data in MM underscores the ...
Hosted on MSN
Bionano raises 2025 OGM installation target to 25 as consumables and software revenue climbs 16%
CEO Robert Erik Holmlin described the second quarter of 2025 as “solid,” emphasizing the positive effects of the strategic shift made in September 2024, which prioritized supporting routine users of ...
This publication appears alongside two other OGM studies in Part II of a series released by Genome Research focusing on long-read methods such as OGM and long-read sequencing (LRS) for genome analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results